Clinical Trials
19 trialsNCT04578613 2023-06-05
ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3 Unknown
NCT05179733 2023-05-23
The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
Ruijin Hospital
Phase 3 Unknown
NCT05332587 2022-05-02
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Unknown
NCT03777085 2019-05-30
Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Unknown
NCT02767674 2019-01-03
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Unknown
NCT03018626 2017-07-28
R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT00209209 2017-03-07
MCLelderly
European Mantle Cell Lymphoma Network
Phase 3 Unknown
NCT01449344 2017-03-07
(R-HAD)
European Mantle Cell Lymphoma Network
Phase 3 Unknown
NCT02772822 2016-05-16
A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients
Sinocelltech Ltd.
Phase 3 Unknown
NCT01933711 2016-05-13
Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma
University Hospital Heidelberg
Phase 3 Unknown
NCT02428751 2015-11-18
R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma
Sun Yat-sen University
Phase 3 Unknown
NCT02423837 2015-04-22
BRiF
National Research Center for Hematology, Russia
Phase 3 Unknown
NCT00028717 2013-09-17
Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00209222 2012-09-10
Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
European Mantle Cell Lymphoma Network
Phase 3 Unknown
NCT01670812 2012-08-22
Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Unknown
NCT00499018 2011-02-15
DLCL04
Fondazione Italiana Linfomi - ETS
Phase 3 Unknown
NCT00435955 2007-02-16
Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma
Azienda Ospedaliera San Giovanni Battista
Phase 3 Unknown
NCT00180882 2006-09-11
LMBA02 Protocol for Patients With a Burkitt Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown
NCT00078598 2005-11-09
A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma
Corixa Corporation
Phase 3 Unknown